488.55MMarket Cap-5182P/E (TTM)
9.500High9.110Low521.86KVolume9.220Open9.290Pre Close4.88MTurnover1.53%Turnover RatioLossP/E (Static)52.08MShares30.99052wk High1.95P/B320.96MFloat Cap5.67052wk Low--Dividend TTM34.22MShs Float72.200Historical High--Div YieldTTM4.20%Amplitude2.190Historical Low9.351Avg Price1Lot Size
EyePoint Pharmaceuticals Stock Forum
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet